Cargando…
Small Non-Coding RNA Profiling Identifies miR-181a-5p as a Mediator of Estrogen Receptor Beta-Induced Inhibition of Cholesterol Biosynthesis in Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is a highly heterogeneous disease, representing the most aggressive breast cancer (BC) subtype with limited treatment options due to a lack of estrogen receptor alpha (ERα), progesterone receptor (PR), and Erb-B2 receptor tyrosine kinase 2 (HER2/neu) expression....
Autores principales: | Alexandrova, Elena, Lamberti, Jessica, Saggese, Pasquale, Pecoraro, Giovanni, Memoli, Domenico, Mirici Cappa, Valeria, Ravo, Maria, Iorio, Roberta, Tarallo, Roberta, Rizzo, Francesca, Collina, Francesca, Cantile, Monica, Di Bonito, Maurizio, Botti, Gerardo, Nassa, Giovanni, Weisz, Alessandro, Giurato, Giorgio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226848/ https://www.ncbi.nlm.nih.gov/pubmed/32260128 http://dx.doi.org/10.3390/cells9040874 |
Ejemplares similares
-
Insights into the Role of Estrogen Receptor β in Triple-Negative Breast Cancer
por: Sellitto, Assunta, et al.
Publicado: (2020) -
Estrogen receptor beta impacts hormone-induced alternative mRNA splicing in breast cancer cells
por: Dago, Dougba Noel, et al.
Publicado: (2015) -
Combinatorial targeting of menin and the histone methyltransferase DOT1L as a novel therapeutic strategy for treatment of chemotherapy-resistant ovarian cancer
por: Alexandrova, Elena, et al.
Publicado: (2022) -
The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei
por: Nassa, Giovanni, et al.
Publicado: (2019) -
The Histone Methyltransferase DOT1L Is a Functional Component of Estrogen Receptor Alpha Signaling in Ovarian Cancer Cells
por: Salvati, Annamaria, et al.
Publicado: (2019)